Treatment-free Remission Accomplished With Dasatinib in Patients With CML
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Dennis Kim, MD
University Health Network, Toronto
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Center
Calgary, Alberta, Canada
- University of Alberta Hospital
Edmonton, Alberta, Canada
- Vancouver General Hospital
Vancouver, British Columbia, Canada
- Cancer Care Manitoba
Winnipeg, Manitoba, Canada
- Queen Elizabeth Ii Health Sciences Centre
Halifax, Nova Scotia, Canada
- Juravinski Cancer Centre
Hamilton, Ontario, Canada
- London Health Sciences Centre
London, Ontario, Canada
- Ottawa General Hospital
Ottawa, Ontario, Canada
- Princess Margaret Cancer Centre
Toronto, Ontario, Canada
- Centre Hôpitallier Universitaire de Quebec - Hôpital de L'Enfant-Jésus
Charlesbourg, Quebec, Canada
- Hopital Maisonneuve-Rosemont
Montreal, Quebec, Canada
- Mcgill University Health Centre
Montreal, Quebec, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2014
- Primary completion
- 31 Oct 2020
- Completion
- 31 Oct 2021
- Last update posted
- 29 Nov 2019
- Registered enrollment
- 131
- Registry id
- NCT02268370
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.